⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27608291 | 0.80 | KMT2A (0.43) | — | |
| SCHEMBL3665940 | 0.80 | ALDH1A1 (0.38) | — | |
| SCHEMBL18541719 | 0.76 | — | — | |
| SCHEMBL1145639 | 0.76 | — | — | |
| SCHEMBL1145637 | 0.76 | — | — | |
| SCHEMBL18312140 | 0.76 | — | — | |
| SCHEMBL30539523 | 0.74 | ALDH1A1 (0.36) | — | |
| SCHEMBL23506373 | 0.73 | — | — | |
| SCHEMBL18541817 | 0.72 | — | — | |
| SCHEMBL455839 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6585996-B1 | Preferably tetrahydrofurfuryl disulfide; administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules | WESTLAKE LABORATORIES, INC. | 2003-07-01 | — | — | US | claimed |
| EP-4642997-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | Baker Hughes Oilfield Operations LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024145404-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240218273-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-07-04 | — | — | US | disclosed |
| CN-110506095-A | Microbial product and its purposes for improving oil recovery | LOCUS OIL IP COMPANY LLC | 2019-11-26 | — | — | CN | disclosed |
| US-9173905-B1 | Nutritional supplement and use thereof | ZYCAL BIOCEUTICALS HEALTHCARE COMPANY, INC. (US) | 2015-11-03 | — | — | US | disclosed |
| EP-2242380-B1 | GRAIN PRODUCTS HAVING A POTENT NATURAL SWEETENER AND A BULKING AGENT | QUAKER OATS CO (US) | 2015-10-21 | — | — | EP | disclosed |
| US-9011930-B2 | Nutritional supplement and use thereof | ZYCAL BIOCEUTICALS HEALTHCARE COMPANY, INC. (US) | 2015-04-21 | — | — | US | disclosed |
| US-20130316050-A1 | NUTRIENT DELIVERY COMPOSITION | LINCOLN MEREDITH BLISS (US) | 2013-11-28 | — | — | US | disclosed |
| EP-2242379-A1 | GRAIN PRODUCTS HAVING A POTENT NATURAL SWEETENER | The Quaker Oats Company (US) | 2010-10-27 | — | — | EP | disclosed |
| US-20020015759-A1 | Nutritionally balanced traditional snack foods | NATIONAL INSTITUTE FOR STRATEGIC TECHNOLOGY ACQUISITION AND COMMERCIALIZATION | 2002-02-07 | — | — | US | disclosed |
| US-20020015760-A1 | Traditional snacks having balanced nutritional profiles | THE PROCTER & GAMBLE COMPANY | 2002-02-07 | — | — | US | disclosed |
| US-20020012722-A1 | Tasty, convenient, nutritionally balanced food compositions | NATIONAL INSTITUTE FOR STRATEGIC TECHNOLOGY ACQUISITION AND COMMERCIALIZATION | 2002-01-31 | — | — | US | disclosed |
| WO-2001078522-A2 | TASTY, CONVENIENT, NUTRITIONALLY BALANCED FOOD COMPOSITIONS | MID-AMERICA COMMERCIALIZATION CORPORATION (US) | 2001-10-25 | — | — | WO | disclosed |
| US-6300324-B1 | LAVENDER FLOWERS, LECITHIN, ALOE, ROSEMARY, THYME, EUCALYPTUS OIL, VITAMIN B1, B6, B12 AND C AND MACERATION, STAINING AND MIXING WITH WATER | PARTELOW SCOTT E (US) | 2001-10-09 | — | — | US | disclosed |
| WO-2001035765-A2 | NUTRITIONAL SUPPLEMENT SYSTEMS FOR POPULATIONS OF WOMEN | TUFTS UNIVERSITY (US) | 2001-05-25 | — | — | WO | disclosed |
| CN-1271579-A | Compound vitamin for health of cardiovascular | BRISTOL MYERS SQUIBB CO (US) | 2000-11-01 | — | — | CN | disclosed |
| EP-1036510-A2 | Vitamin formulation for cardiovascular health | Bristol-Myers Company (US) | 2000-09-20 | — | — | EP | disclosed |
| US-5770215-A | Multivitamin/vascular occlusion inhibiting composition | MOSHYEDI EMIL PAYMAN (US) | 1998-06-23 | — | — | US | disclosed |
| WO-1996013179-A2 | NUTRIENT SUPPLEMENT COMPOSITIONS PROVIDING PHYSIOLOGIC FEEDBACK | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-09 | — | — | WO | disclosed |